Uncategorized Archives - HealthCare Royalty

November 2, 2023

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

October 24, 2023

HealthCare Royalty Announces Closing of Credit Facility, New Debt Focused Fund and Appointment of Josh House as West Coast Lead

August 22, 2023

TheracosBio Announces Royalty Financing Agreement with HealthCare Royalty

August 3, 2023

Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty

May 15, 2023

uniQure Announces Sale of Royalty Interest in HEMGENIX ^® for Up To $400 Million

January 9, 2023

Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million

December 21, 2022

Atara Biotherapeutics Announces $31 Million Royalty Interest Financing Agreement with HealthCare Royalty

June 30, 2022

Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners

June 16, 2022

Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 Million

June 24, 2021

Karyopharm Announces Expansion Of Royalty Agreement With Healthcare Royalty For Up To $100 Million